Browse by category

BELIEVE study to assess Bimagrumab as treatment for obesity

Versanis Bio, a clinical-stage biopharmaceutical company advancing novel therapeutics for cardiometabolic diseases, has announced that...

GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour

13 hours ago

Bariatric surgery induces changes in taste perception, desire and enjoyment of flavours

16 hours ago

Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss

17 hours ago

Weekly Digest